Molecular Profiling of Liquid Biopsy Samples for Precision Medicine.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cancer Journal

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/PPO.0000000000000311PMID 29601336PMCID PMC5880307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection

  2017cited by this paper
• Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression

  2017cited by this paper
• Exosomes maintain cellular homeostasis by excreting harmful DNA from cells

  2017cited by this paper
• Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?

  2017cited by this paper
• Extracellular vesicles or free circulating DNA: where to search for BRAF and cKIT mutations?

  2017cited by this paper
• Circulating-tumor DNA as an early detection and diagnostic tool.

  2017cited by this paper
• Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

  2017cited by this paper
• Liquid biopsies come of age: towards implementation of circulating tumour DNA

  2017cited by this paper
• Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine.

  2017cited by this paper
• Exosomes: New players in cancer

  2017cited by this paper
• Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule

  2017cited by this paper
• Extracellular Vesicles in Cardiovascular Disease: Potential Applications in Diagnosis, Prognosis, and Epidemiology

  2017cited by this paper
• New insights in non-small-cell lung cancer: circulating tumor cells and cell-free DNA.

  2017cited by this paper
• RNA in extracellular vesicles

  2017cited by this paper
• Role of tumor microenvironment in tumorigenesis

  2017cited by this paper
• Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.

  2017cited by this paper
• Advances in Circulating Tumor DNA Analysis.

  2017cited by this paper
• Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits

  2017cited by this paper
• Duplex Proximity Sequencing (Pro-Seq): A method to improve DNA sequencing accuracy without the cost of molecular barcoding redundancy

  2017cited by this paper
• Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies

  2016cited by this paper
• Fragment Length of Circulating Tumor DNA

  2016cited by this paper
• Communication by Extracellular Vesicles: Where We Are and Where We Need to Go.

  2016cited by this paper
• Origins, structures, and functions of circulating DNA in oncology

  2016cited by this paper
• New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies

  2016cited by this paper
• Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer

  2016cited by this paper
• Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery

  2016cited by this paper
• Cancer: hunting rare somatic mutations

  2016cited by this paper
• The emerging role of lncRNAs in cancer

  2015cited by this paper
• Sequencing small genomic targets with high efficiency and extreme accuracy

  2015cited by this paper
• Circulating tumor-derived DNA is shorter than somatic DNA in plasma

  2015cited by this paper
• Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

  2015cited by this paper
• Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma

  2015cited by this paper
• Targeted single molecule mutation detection with massively parallel sequencing

  2015cited by this paper
• Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience

  2015cited by this paper
• Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma

  2015cited by this paper
• miRNA in situ hybridization in circulating tumor cells - MishCTC

  2015cited by this paper
• Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

  2015cited by this paper
• Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?: A Report of the Association for Molecular Pathology.

  2015cited by this paper
• Extracellular Vesicles in Cardiovascular Disease

  2014cited by this paper
• Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.

  2014cited by this paper
• Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

  2014cited by this paper
• Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies

  2014cited by this paper
• Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor

  2014cited by this paper
• Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer*

  2014cited by this paper
• Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration

  2014cited by this paper
• Quantitative and stoichiometric analysis of the microRNA content of exosomes

  2014cited by this paper
• Expression profiling of circulating tumor cells in metastatic breast cancer

  2014cited by this paper
• Whole exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

  2014cited by this paper
• An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

  2013cited by this paper
• Going with the Flow: From Circulating Tumor Cells to DNA

  2013cited by this paper
• On the origin of cancer metastasis.

  2013cited by this paper
• Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.

  2013cited by this paper
• Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers

  2013cited by this paper
• Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection

  2013cited by this paper
• Circulating cell free DNA: Preanalytical considerations.

  2013cited by this paper
• Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

  2012cited by this paper
• Detection of ultra-rare mutations by next-generation sequencing

  2012cited by this paper
• The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

  2012cited by this paper
• Full-Length mRNA-Seq from single cell levels of RNA and individual circulating tumor cells

  2012cited by this paper
• Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods.

  2012cited by this paper
• The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes

  2012cited by this paper
• Detection and quantification of rare mutations with massively parallel sequencing

  2011cited by this paper
• Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping.

  2011cited by this paper
• PCR/LDR/universal array platforms for the diagnosis of infectious disease.

  2010cited by this paper
• Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

  2010cited by this paper
• Comptes Rendus des Séances de la Société de Biologie et de ses Filiales

  2009cited by this paper
• Characterization of circulating tumor cells by fluorescence in situ hybridization

  2009cited by this paper
• Peptide nucleic acid–locked nucleic acid polymerase chain reaction clamp‐based detection test for gefitinib‐refractory T790M epidermal growth factor receptor mutation

  2008cited by this paper
• Circulating tumor cells in the management of metastatic breast cancer patients

  2007cited by this paper
• Isolation of rare circulating tumour cells in cancer patients by microchip technology

  2007cited by this paper
• The struggle to detect circulating DNA

  2006cited by this paper
• Global gene expression profiling of circulating tumor cells.

  2005cited by this paper
• Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

  2004cited by this paper
• Amount of DNA in plasma and cancer risk: A prospective study

  2004cited by this paper
• DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

  2001cited by this paper
• Ligase detection reaction for identification of low abundance mutations.

  1999cited by this paper
• Free DNA in the serum of cancer patients and the effect of therapy.

  1977cited by this paper
• Les acides nucleiques du plasma sanguin chez l' homme

  1948cited by this paper
• [Not Available].

  1948cited by this paper

• Liquid Biopsy and Molecular Biomarkers in Mucinous Appendiceal and Colorectal Tumors: Current Evidence and Unmet Challenges in Precision Oncology.

  2026cites this paper
• Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment

  2025cites this paper
• Early Cancer Biomarker Discovery Using DIA-MS Proteomic Analysis of EVs from Peripheral Blood.

  2023cites this paper
• Liquid Biopsy: New Kid on the Block

  2023cites this paper
• Microfluidics engineering towards personalized oncology—a review

  2023influential citation
• Fabrication of Multilayer Microfluidic Arrays for Passive, Efficient DNA Trapping and Profiling.

  2023cites this paper
• Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer

  2023cites this paper
• High sensitivity detection of tumor cells in biological samples using a multivalent aptamer strand displacement strategy.

  2022cites this paper
• Label-Free Identification of Single Mononucleotides by Nanoscale Electrophoresis.

  2021cites this paper
• Retos y oportunidades en el estudio de vesículas extracelulares: contexto institucional a nivel mundial y situación actual en Colombia

  2021cites this paper
• Challenges of an Emerging Disease: The Evolving Approach to Diagnosing Devil Facial Tumour Disease

  2021cites this paper
• Targeting tumor resistance mechanisms

  2021cites this paper
• Nanobodies for Medical Imaging: About Ready for Prime Time?

  2021cites this paper
• Current Advances in Clinical Application of Liquid Biopsy

  2021cites this paper
• Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

  2021cites this paper
• Analytical Technologies for Liquid Biopsy of Subcellular Materials.

  2021cites this paper
• Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma

  2020cites this paper
• Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer

  2020cites this paper
• Visible photorelease of liquid biopsy markers following microfluidic affinity-enrichment.

  2020cites this paper
• Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’

  2020cites this paper
• Liquid biopsy for the detection of clinical biomarkers in early breast cancer: new insights and challenges.

  2020cites this paper
• Liquid biopsy technologies for hematological diseases

  2020cites this paper
• Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long-Term Survival in Pancreatic Cancer

  2020cites this paper
• Prediction of the treatment response in ovarian cancer: a ctDNA approach

  2020cites this paper
• Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes

  2020cites this paper
• Multilayer microfluidic array for highly efficient sample loading and digital melt analysis of DNA methylation.

  2019cites this paper
• CMAR_A_201326 7525..7536

  2019cites this paper
• Cell Separations and Sorting.

  2019cites this paper
• Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer

  2019cites this paper
• Precision oncology: lessons learned and challenges for the future

  2019cites this paper
• Intra‐individual variation of circulating tumour DNA in lung cancer patients

  2019cites this paper
• Ultrasensitive Detection of Circulating Tumor DNA in Lymphoma via Targeted Hybridization Capture and Deep Sequencing of Barcoded Libraries.

  2019cites this paper
• Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications

  2019cites this paper
• Are liquid biopsies ready for primetime?

  2018cites this paper
• Microfluidic-based solid phase extraction of cell free DNA.

  2018cites this paper
• Early-Stage Detection of Hepatocellular Carcinoma: The Oncoguard ™ Liver Solution

  year unknowncites this paper